We demonstrated that NLOC-015A inhibited the proliferation 9 cell line panel of NSCLC with concomitant downregulation of expression levels of oncogenic molecules, including EGFR, mTOR, Akt, NF-κB, YAP1, MEK signaling network. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.